Praxis Bioresearch Inc.
Los Angeles, CA
- UEI
- YANFQK2N14K8
- CAGE
- 7HXX8
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 10940 Wilshire Blvd STE 600, Los Angeles, CA 90024, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Novel dopaminergic stimulant prodrug for the treatment of apathy in ad | National Institute on Aging (NIH) | $7,774,675 | |
| Validating prodrug PRX-P4-003 approach in humans by phase 0 microdose study | National Institute of Mental Health (NIH) | $1,556,617 |
Quick answers
Is Praxis Bioresearch Inc. registered in SAM.gov?
Yes. Praxis Bioresearch Inc.'s SAM.gov registration is active through April 9, 2027.
What is Praxis Bioresearch Inc.'s most recent federal award?
Praxis Bioresearch Inc.'s most recent federal grant award is Novel dopaminergic stimulant prodrug for the treatment of apathy in ad (R44AG066378), from National Institute on Aging (NIH), on August 15, 2020.
On GovTribe
See Praxis Bioresearch Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors